2026 Q2 Portfolio Activity
In 2026 Q2, Propel Bio Management, LLC maintained a portfolio of 42 distinct positions. The most significant new addition was SILENCE THERAPEUTICS PLC, now representing 1.10% of the total fund value. They heavily accumulated shares in ACHIEVE LIFE SCIENCES INC, increasing the position by 6.5%. Conversely, Propel Bio Management, LLC completely exited their position in VOR BIOPHARMA INC.
Position History
hover any row below to update
Loading…
Total Positions
42
Quarter
2026 Q2
Top Holding
PAGP (16.2%)
Top 10 Concentration
68.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-42 of 42
Propel Bio Management, LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PAGP
PLAINS GP HOLDI...
|
Energy | 16.16% | 19.02% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
1,272,360 | $30,880,177 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ACHV
ACHIEVE LIFE SC...
|
Healthcare | 13.79% | 7.17% |
#2
Prev: #2
|
7.5 |
—
|
247,593 | 6.5% |
P
S
|
4,034,018 | $26,342,138 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CORT
CORCEPT THERAPE...
|
Healthcare | 6.21% | 3.80% |
#3
2
Prev: #5
|
4.0 |
—
|
-11,329 | -7.7% |
P
S
|
136,499 | $11,868,588 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
PHAT
PHATHOM PHARMAC...
|
Healthcare | 5.96% | 5.90% |
#4
1
Prev: #3
|
5.4 |
—
|
209,086 | 24.9% |
P
S
|
1,050,358 | $11,396,384 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
DCTH
DELCATH SYSTEMS...
|
Healthcare | 5.74% | 5.77% |
#5
1
Prev: #4
|
3.3 |
—
|
-108,238 | -11.0% |
P
S
|
871,460 | $10,971,681 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
MIST
MILESTONE PHARM...
|
Healthcare | 5.21% | 3.20% |
#6
3
Prev: #9
|
5.1 |
—
|
3,311,269 | 80.4% |
P
S
|
7,429,590 | $9,955,651 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 4.24% | 2.60% |
#7
4
Prev: #11
|
1.7 |
—
|
-168,963 | -22.8% |
P
S
|
573,086 | $8,109,167 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
KYTX
KYVERNA THERAPE...
|
Healthcare | 4.12% | 3.52% |
#8
Prev: #8
|
4.1 |
—
|
238,777 | 37.1% |
P
S
|
883,198 | $7,869,294 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ARTV
ARTIVA BIOTHERA...
|
Healthcare | 3.54% | 0.60% |
#9
27
Prev: #36
|
4.4 |
—
|
550,067 | 375.8% |
P
S
|
696,436 | $6,755,429 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ABEO
ABEONA THERAPEU...
|
Healthcare | 3.18% | 3.79% |
#10
4
Prev: #6
|
1.3 |
—
|
-346,829 | -26.1% |
P
S
|
983,070 | $6,075,373 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
AQST
AQUESTIVE THERA...
|
Healthcare | 3.14% | 1.86% |
#11
9
Prev: #20
|
4.3 |
—
|
731,409 | 102.9% |
P
S
|
1,442,397 | $6,000,372 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
PALI
PALISADE BIO IN...
|
Healthcare | 2.82% | 1.26% |
#12
15
Prev: #27
|
4.1 |
—
|
1,467,388 | 131.6% |
P
S
|
2,582,388 | $5,397,191 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
N/A
IMMUNIC INC
|
|
Unknown | 2.61% | — |
#13
Prev: #—
|
4.5 |
—
|
325,022 | — |
NEW
|
325,022 | $4,995,588 | — | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
IVA
INVENTIVA SA - ...
|
Healthcare | 2.53% | 2.52% |
#14
1
Prev: #13
|
4.0 |
—
|
556,534 | 76.8% |
P
S
|
1,281,212 | $4,842,981 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
SABS
SAB BIOTHERAPEU...
|
Healthcare | 2.20% | 2.45% |
#15
1
Prev: #14
|
2.9 |
—
|
63,788 | 6.3% |
P
S
|
1,076,578 | $4,198,654 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
OBIO
ORCHESTRA BIOME...
|
Healthcare | 2.02% | 2.41% |
#16
1
Prev: #15
|
1.8 |
—
|
no change | no change |
P
S
|
896,701 | $3,869,265 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 2.02% | 2.61% |
#17
7
Prev: #10
|
0.8 |
—
|
-27,669 | -21.1% |
P
S
|
103,695 | $3,858,491 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ZVRA
ZEVRA THERAPEUT...
|
Healthcare | 1.90% | 1.66% |
#18
5
Prev: #23
|
1.3 |
—
|
-28,874 | -10.2% |
P
S
|
253,544 | $3,635,821 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 1.84% | 2.03% |
#19
1
Prev: #18
|
1.2 |
—
|
-24,409 | -6.4% |
P
S
|
357,966 | $3,515,226 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
FDMT
4D MOLECULAR TH...
|
Healthcare | 1.76% | 2.26% |
#20
4
Prev: #16
|
0.7 |
—
|
-127,766 | -33.6% |
P
S
|
252,654 | $3,360,298 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
OVID
OVID THERAPEUTI...
|
Healthcare | 1.57% | 1.28% |
#21
5
Prev: #26
|
3.1 |
—
|
194,081 | 21.1% |
P
S
|
1,115,538 | $3,000,797 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
EYPT
EYEPOINT INC
|
Healthcare | 1.43% | 1.76% |
#22
1
Prev: #21
|
1.1 |
—
|
-24,080 | -11.2% |
P
S
|
191,745 | $2,741,954 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
UPB
UPSTREAM BIO IN...
|
Healthcare | 1.27% | 1.95% |
#23
4
Prev: #19
|
1.0 |
—
|
8,610 | 2.5% |
P
S
|
350,389 | $2,424,692 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
N/A
SCYNEXIS INC
|
|
Unknown | 1.16% | — |
#24
Prev: #—
|
4.0 |
—
|
543,478 | — |
NEW
|
543,478 | $2,211,955 | — | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
SLN
SILENCE THERAPE...
|
Healthcare | 1.10% | — |
#25
Prev: #—
|
3.9 |
—
|
191,733 | — |
NEW
|
191,733 | $2,105,228 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
LONA
LEONABIO INC
|
Healthcare | 0.72% | 0.94% |
#26
4
Prev: #30
|
1.3 |
—
|
no change | no change |
P
S
|
149,279 | $1,371,874 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 0.68% | 0.82% |
#27
5
Prev: #32
|
1.3 |
—
|
no change | no change |
P
S
|
43,798 | $1,306,932 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CRVS
CORVUS PHARMACE...
|
Healthcare | 0.55% | 0.79% |
#28
6
Prev: #34
|
0.7 |
—
|
-15,411 | -18.0% |
P
S
|
70,380 | $1,051,477 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
SGMT
SAGIMET BIOSCIE...
|
Healthcare | 0.51% | — |
#29
Prev: #—
|
3.7 |
—
|
125,878 | — |
NEW
|
125,878 | $973,037 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
N/A
SATELLOS BIOSCI...
|
|
Unknown | 0.00% | 0.04% |
Sold All 😨
(Was: #38) |
0.0 |
—
|
-10,145 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
N/A
CONNECT BIOPHAR...
|
|
Unknown | 0.00% | 0.35% |
Sold All 😨
(Was: #37) |
0.0 |
—
|
-209,493 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
ALDX
ALDEYRA THERAPE...
|
Healthcare | 0.00% | 0.78% |
Sold All 😨
(Was: #35) |
0.0 |
—
|
-730,606 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
EVMN
EVOMMUNE INC
|
Healthcare | 0.00% | 0.81% |
Sold All 😨
(Was: #33) |
0.0 |
—
|
-55,664 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
NUVB
NUVATION BIO IN...
|
Healthcare | 0.00% | 0.89% |
Sold All 😨
(Was: #31) |
0.0 |
—
|
-329,296 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
QURE
UNIQURE NV
|
Healthcare | 0.00% | 1.08% |
Sold All 😨
(Was: #29) |
0.0 |
—
|
-104,772 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
KLRS
KALARIS THERAPE...
|
Healthcare | 0.00% | 1.08% |
Sold All 😨
(Was: #28) |
0.0 |
—
|
-295,771 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CHRS
COHERUS ONCOLOG...
|
Healthcare | 0.00% | 1.52% |
Sold All 😨
(Was: #25) |
0.0 |
—
|
-1,420,550 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
IMUX
IMMUNIC INC
|
Healthcare | 0.00% | 1.65% |
Sold All 😨
(Was: #24) |
0.0 |
—
|
-2,344,779 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 0.00% | 1.67% |
Sold All 😨
(Was: #22) |
0.0 |
—
|
-223,802 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
OCS
OCULIS HOLDING ...
|
Healthcare | 0.00% | 2.07% |
Sold All 😨
(Was: #17) |
0.0 |
—
|
-122,223 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 0.00% | 2.58% |
Sold All 😨
(Was: #12) |
0.0 |
—
|
-210,163 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 0.00% | 3.52% |
Sold All 😨
(Was: #7) |
0.0 |
—
|
-314,543 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 |
Showing 1-42 of 42 holdings